Razer had a variety of gaming tech including an AI esports coach and new RTX 5090 laptops which we all saw in action; here's ...

The Razer Handheld Dock Chroma will bring RGB lighting and plenty of ports to your Steam Deck for $79.99 on January 30, but ...

Razer brought a fancypants monitor stand to CES 2025 in Las Vegas, and this one features RGB lights. The Chroma stand is an ...

Diamondback Energy has a solid financial profile despite its acquisition-fueled growth over the years. It ended the third quarter with $12.7 billion of net debt following the Endeavor deal. That's ...

In this article, we are going to look at where Diamondback Energy, Inc. (NYSE:FANG) stands against other best undervalued energy stocks to buy according to hedge funds. Despite the stated goal of ...

The latest model to do this is the all-stainless steel Diamondback Firearms SDR. Here is a closer look at what this new snub-gun has to offer. The SDR is Diamondback’s first defensive revolver.

Diamondback, Halliburton, and VoltaGrid partner to deploy advanced electric simul-frac fleets in the Permian Basin. Collaboration integrates low-carbon technologies to enhance reliability ...

HOUSTON, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy (NYSE: FANG), Halliburton Energy Services (NYSE: HAL), and VoltaGrid LLC have entered into a landmark agreement to deploy four ...

In this article, we are going to look at where Diamondback Energy, Inc. (NASDAQ:FANG) stands against other most profitable natural gas stocks to invest in. On November 4, the Canadian government ...

Chroma Medicine and Nvelop Therapeutics merge to bring together best-in-class epigenetic editing technologies and next generation in vivo delivery technologies to unlock the full potential of ...

Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio. The merger will combine molecular machines ...

Epigenetic editing startup Chroma Medicine is merging with Nvelop Therapeutics in a deal that will also bring in $75 million in funding to develop in vivo genetic medicines, the two companies ...